Tamiflu (Oseltamivir)

Modified on 2009/10/14 21:53 by admin

Tamiflu (Oseltamivir) helps combat the spread of influenza A and B, viruses responsible for the flu.  Tamiflu is not a substitute for early vaccination on an annual basis as recommended by the CDC advisory committee on immunization practices.  The drug attacks the virus that causes the flu, rather than camouflaging flu symptoms as many drugs do.

Tamiflu is indicated for treatment of influenza A and B in patients one year and older.  Tamiflu can also prevent the chances of getting the flu in a household where others are infected with the flu. Tamiflu is also appropriate for those whose flu symptoms have started in past few days.  Some of these flu symptoms may include fever, chills, a runny nose, a cough, a sore throat, muscle aches, body aches, and fatigue.

Recently there have been numerous reports of Tamiflu causing abnormal psychiatric behavior in children and young adults.  The FDA has recorded at least twenty-two adverse event reports as serious in the U.S. involving situations such as delirium and delusions with Tamiflu.  There have been no deaths in the United States attributed to the drug, but in Japan there were at least fifteen child deaths attributable to neuropsychiatric events and Tamiflu.  Japan was the first country to recognize the association between the drug Tamiflu and neurological and psychiatric problems.

  Name Size